P687 Ozanimod as a once-daily oral therapy for Japanese patients with ulcerative colitis: results from the induction period of a Phase 2/3 study (J-True North)

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2024-01, Vol.18 (Supplement_1), p.i1305-i1306
Main Authors: Matsuoka, K, Nakase, H, Fujii, T, Hisamatsu, T, Suzuki, Y, Watanabe, M, Uchikawa, Y, Goto, S, Fujimoto, G, Zhang, C, Hibi, T
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page i1306
container_issue Supplement_1
container_start_page i1305
container_title Journal of Crohn's and colitis
container_volume 18
creator Matsuoka, K
Nakase, H
Fujii, T
Hisamatsu, T
Suzuki, Y
Watanabe, M
Uchikawa, Y
Goto, S
Fujimoto, G
Zhang, C
Hibi, T
description
doi_str_mv 10.1093/ecco-jcc/jjad212.0817
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ecco_jcc_jjad212_0817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_ecco_jcc_jjad212_0817</sourcerecordid><originalsourceid>FETCH-LOGICAL-c937-ca164948307cf5df3b077eccca3a381b63fa26c675fff03bf49eb7387085171d3</originalsourceid><addsrcrecordid>eNot0M1OhDAUBWBiNHEcfQSTu9QFMy0FCu7MxL_JxJnF7MmltKGEoaQtGnwZX1VQV_cuTs5JviC4pWRFSc7WUggTNkKsmwariEYrklF-FixoxtMwjnl-_vuzMM_j9DK4cq4hJMkTni2C70Oacdh_YadPpgJ0gGA6IcMKdTuCsdiCr6XFfgRlLGyxx046CT16LTvv4FP7GoZWTBmvPyQI02qv3QNY6YZ2CihrTnMH6K4ahNemg15aPa0ZNa0dapzqojUD54dqhLtteLSDhHdjfX1_HVwobJ28-b_L4Pj8dNy8hrv9y9vmcReKnPFQIE3jPM4Y4UIllWIl4XxiEciQZbRMmcIoFSlPlFKElSrOZclZxkmWUE4rtgySv1phjXNWqqK3-oR2LCgpZuRiRi4m5OIfuZiR2Q_JVHVy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P687 Ozanimod as a once-daily oral therapy for Japanese patients with ulcerative colitis: results from the induction period of a Phase 2/3 study (J-True North)</title><source>Oxford Journals Online</source><creator>Matsuoka, K ; Nakase, H ; Fujii, T ; Hisamatsu, T ; Suzuki, Y ; Watanabe, M ; Uchikawa, Y ; Goto, S ; Fujimoto, G ; Zhang, C ; Hibi, T</creator><creatorcontrib>Matsuoka, K ; Nakase, H ; Fujii, T ; Hisamatsu, T ; Suzuki, Y ; Watanabe, M ; Uchikawa, Y ; Goto, S ; Fujimoto, G ; Zhang, C ; Hibi, T</creatorcontrib><identifier>ISSN: 1873-9946</identifier><identifier>EISSN: 1876-4479</identifier><identifier>DOI: 10.1093/ecco-jcc/jjad212.0817</identifier><language>eng</language><ispartof>Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1305-i1306</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Matsuoka, K</creatorcontrib><creatorcontrib>Nakase, H</creatorcontrib><creatorcontrib>Fujii, T</creatorcontrib><creatorcontrib>Hisamatsu, T</creatorcontrib><creatorcontrib>Suzuki, Y</creatorcontrib><creatorcontrib>Watanabe, M</creatorcontrib><creatorcontrib>Uchikawa, Y</creatorcontrib><creatorcontrib>Goto, S</creatorcontrib><creatorcontrib>Fujimoto, G</creatorcontrib><creatorcontrib>Zhang, C</creatorcontrib><creatorcontrib>Hibi, T</creatorcontrib><title>P687 Ozanimod as a once-daily oral therapy for Japanese patients with ulcerative colitis: results from the induction period of a Phase 2/3 study (J-True North)</title><title>Journal of Crohn's and colitis</title><issn>1873-9946</issn><issn>1876-4479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNot0M1OhDAUBWBiNHEcfQSTu9QFMy0FCu7MxL_JxJnF7MmltKGEoaQtGnwZX1VQV_cuTs5JviC4pWRFSc7WUggTNkKsmwariEYrklF-FixoxtMwjnl-_vuzMM_j9DK4cq4hJMkTni2C70Oacdh_YadPpgJ0gGA6IcMKdTuCsdiCr6XFfgRlLGyxx046CT16LTvv4FP7GoZWTBmvPyQI02qv3QNY6YZ2CihrTnMH6K4ahNemg15aPa0ZNa0dapzqojUD54dqhLtteLSDhHdjfX1_HVwobJ28-b_L4Pj8dNy8hrv9y9vmcReKnPFQIE3jPM4Y4UIllWIl4XxiEciQZbRMmcIoFSlPlFKElSrOZclZxkmWUE4rtgySv1phjXNWqqK3-oR2LCgpZuRiRi4m5OIfuZiR2Q_JVHVy</recordid><startdate>20240124</startdate><enddate>20240124</enddate><creator>Matsuoka, K</creator><creator>Nakase, H</creator><creator>Fujii, T</creator><creator>Hisamatsu, T</creator><creator>Suzuki, Y</creator><creator>Watanabe, M</creator><creator>Uchikawa, Y</creator><creator>Goto, S</creator><creator>Fujimoto, G</creator><creator>Zhang, C</creator><creator>Hibi, T</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20240124</creationdate><title>P687 Ozanimod as a once-daily oral therapy for Japanese patients with ulcerative colitis: results from the induction period of a Phase 2/3 study (J-True North)</title><author>Matsuoka, K ; Nakase, H ; Fujii, T ; Hisamatsu, T ; Suzuki, Y ; Watanabe, M ; Uchikawa, Y ; Goto, S ; Fujimoto, G ; Zhang, C ; Hibi, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c937-ca164948307cf5df3b077eccca3a381b63fa26c675fff03bf49eb7387085171d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsuoka, K</creatorcontrib><creatorcontrib>Nakase, H</creatorcontrib><creatorcontrib>Fujii, T</creatorcontrib><creatorcontrib>Hisamatsu, T</creatorcontrib><creatorcontrib>Suzuki, Y</creatorcontrib><creatorcontrib>Watanabe, M</creatorcontrib><creatorcontrib>Uchikawa, Y</creatorcontrib><creatorcontrib>Goto, S</creatorcontrib><creatorcontrib>Fujimoto, G</creatorcontrib><creatorcontrib>Zhang, C</creatorcontrib><creatorcontrib>Hibi, T</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of Crohn's and colitis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsuoka, K</au><au>Nakase, H</au><au>Fujii, T</au><au>Hisamatsu, T</au><au>Suzuki, Y</au><au>Watanabe, M</au><au>Uchikawa, Y</au><au>Goto, S</au><au>Fujimoto, G</au><au>Zhang, C</au><au>Hibi, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P687 Ozanimod as a once-daily oral therapy for Japanese patients with ulcerative colitis: results from the induction period of a Phase 2/3 study (J-True North)</atitle><jtitle>Journal of Crohn's and colitis</jtitle><date>2024-01-24</date><risdate>2024</risdate><volume>18</volume><issue>Supplement_1</issue><spage>i1305</spage><epage>i1306</epage><pages>i1305-i1306</pages><issn>1873-9946</issn><eissn>1876-4479</eissn><doi>10.1093/ecco-jcc/jjad212.0817</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1873-9946
ispartof Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1305-i1306
issn 1873-9946
1876-4479
language eng
recordid cdi_crossref_primary_10_1093_ecco_jcc_jjad212_0817
source Oxford Journals Online
title P687 Ozanimod as a once-daily oral therapy for Japanese patients with ulcerative colitis: results from the induction period of a Phase 2/3 study (J-True North)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T05%3A14%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P687%20Ozanimod%20as%20a%20once-daily%20oral%20therapy%20for%20Japanese%20patients%20with%20ulcerative%20colitis:%20results%20from%20the%20induction%20period%20of%20a%20Phase%202/3%20study%20(J-True%20North)&rft.jtitle=Journal%20of%20Crohn's%20and%20colitis&rft.au=Matsuoka,%20K&rft.date=2024-01-24&rft.volume=18&rft.issue=Supplement_1&rft.spage=i1305&rft.epage=i1306&rft.pages=i1305-i1306&rft.issn=1873-9946&rft.eissn=1876-4479&rft_id=info:doi/10.1093/ecco-jcc/jjad212.0817&rft_dat=%3Ccrossref%3E10_1093_ecco_jcc_jjad212_0817%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c937-ca164948307cf5df3b077eccca3a381b63fa26c675fff03bf49eb7387085171d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true